Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
about
A review on leukotrienes and their receptors with reference to asthmaUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonistCysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury.Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanomaEicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Focus on cutaneous and uveal melanoma specificities.Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.Discovery of Highly Potent Dual CysLT1 and CysLT2 Antagonist.Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.Leukotrienes orchestrating allergic skin inflammation.Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
P2860
Q28294597-915AE56F-25E6-4092-AA53-94924BC99EFDQ28308192-FA0C8658-4080-411B-8157-432363107978Q30234961-26B6321E-48C1-413F-929C-08C771D4A28EQ33823711-5EF88A32-D249-4856-8380-48E61886F017Q33964630-682EE7DA-DDC5-40CA-A016-515FFA3A9594Q36339008-837BC63D-4EDE-479A-AC6F-62AE3BC0A0B3Q36681733-D25744F5-EF7F-4D84-9DCE-A79B1C0CA54DQ37131972-7CACFB1C-1E0F-4DC0-918A-AFEE78254F69Q37274872-4C598606-2077-4ABE-A009-08ECC5FD5EAFQ37995534-2A6AE530-009B-485A-A0AC-7A33DE8CB5B0Q38728679-3D36EEE9-C884-44F9-870D-1698C2E365DAQ39312161-BF80693E-D663-4F73-A82A-5329223BEBCEQ39500070-7A7C34B3-5ABC-4818-A530-1E2B6A543696Q41432422-8AFB9C25-8717-49E5-A19C-8343A9BBE730Q41992838-977CDB4E-5100-471B-A9F1-B913D11E689FQ42101040-B2CBD8C4-C0CC-4F11-94E0-C0C7672C4B75Q44790126-08E7BF73-9647-4C43-967E-885B00528CF9Q45348897-15C231E3-FE5F-45D5-8660-BED4647CFC7EQ50063675-4A0ACE32-1A08-4F65-A6EB-3BE8FDC575F0
P2860
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Pharmacological characterizati ...... otriene 2 (CysLT(2)) receptor.
@en
Pharmacological characterizati ...... at the cysteinyl leukotriene 2
@nl
type
label
Pharmacological characterizati ...... otriene 2 (CysLT(2)) receptor.
@en
Pharmacological characterizati ...... at the cysteinyl leukotriene 2
@nl
prefLabel
Pharmacological characterizati ...... otriene 2 (CysLT(2)) receptor.
@en
Pharmacological characterizati ...... at the cysteinyl leukotriene 2
@nl
P2093
P2860
P1476
Pharmacological characterizati ...... otriene 2 (CysLT(2)) receptor.
@en
P2093
E M Becker
P2860
P304
P356
10.1111/J.1476-5381.2010.00730.X
P407
P577
2010-05-01T00:00:00Z